Showing results (1471-1480 of 2,677) with videos related to
Sort By:
Pageof 268
Journal of Hospital Medicine|May 28, 2015
Safety of peripheral intravenous administration of vasoactive medicationJose Cardenas-Garcia, Karen F Schaub, Yuly G Belchikov, et al.Blood|January 12, 2010
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasmsFranz X Schaub, Renate Looser, Sai Li, et al.Allergy|October 14, 2024
Farm-dust mediated protection of childhood asthma: Mass cytometry reveals novel cellular regulationClaudia Carina Beerweiler, Michael Salvermoser, Johanna Theodorou, et al.The Journal of Thoracic and Cardiovascular Surgery|January 1, 1990
Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alphaS C Yang, L Owen-Schaub, A Mendiguren-Rodriguez, et al.Journal of Behavioral Addictions|May 14, 2019
Problematic smartphone use in young Swiss men: Its association with problematic substance use and risk factors derived from the pathway modelMichelle Dey, Joseph Studer, Michael Patrick Schaub, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|February 22, 2011
Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantationsPatrizia Amico, Patricia Hirt-Minkowski, Gideon Hönger, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2010
Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipientsAshley N Miller, Ashley Glode, Kathy R Hogan, et al.Transplantation Proceedings|September 1, 2009
Deazaadenosine prevents leukozyte evasion during acute cardiac allograft rejection by suppression of adhesion molecule expressionH Fingerhuth, H Hölschermann, H Grimm, et al.International Journal of Molecular Sciences|June 21, 2020
Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal AntibodyNishant P Patel, Peng Guan, Devika Bahal, et al.Cancer Letters|July 20, 1995
Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?L B Owen-Schaub, L S Angelo, R Radinsky, et al.Pageof 268